Us Bancorp \De\ Artivion, Inc. Transaction History
Us Bancorp \De\
- $78.3 Billion
- Q2 2025
A detailed history of Us Bancorp \De\ transactions in Artivion, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 340 shares of AORT stock, worth $13,923. This represents 0.0% of its overall portfolio holdings.
Number of Shares
340
Previous 422
19.43%
Holding current value
$13,923
Previous $10,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AORT
# of Institutions
186Shares Held
38.5MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$272 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$119 Million0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.8MShares$115 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$114 Million2.87% of portfolio
-
Morgan Stanley New York, NY2.26MShares$92.6 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.65B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...